These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1829542)

  • 1. [Receptor of cells with infection of AIDS virus].
    Xu TG
    Sheng Li Ke Xue Jin Zhan; 1991 Jan; 22(1):29-33. PubMed ID: 1829542
    [No Abstract]   [Full Text] [Related]  

  • 2. [Binding of HIV-1 by "soluble" CD4 receptor--new therapeutic possibilities in AIDS].
    Nowak J
    Pol Tyg Lek; 1989 Apr; 44(17):401-2. PubMed ID: 2533976
    [No Abstract]   [Full Text] [Related]  

  • 3. AIDS and immune dysfunction. Alternative etiologic mechanisms.
    del Guercio P
    Contrib Microbiol Immunol; 1989; 11():289-304. PubMed ID: 2573482
    [No Abstract]   [Full Text] [Related]  

  • 4. A mechanism of resistance to HIV-1 entry: inefficient interactions of CXCR4 with CD4 and gp120 in macrophages.
    Dimitrov DS; Norwood D; Stantchev TS; Feng Y; Xiao X; Broder CC
    Virology; 1999 Jun; 259(1):1-6. PubMed ID: 10364484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interaction between HIV and CD4 antigen and application of CD4 derivatives to AIDS therapy].
    Mizukami T
    Tanpakushitsu Kakusan Koso; 1990 Mar; 35(3):225-35. PubMed ID: 1691857
    [No Abstract]   [Full Text] [Related]  

  • 6. Soluble CD4: another therapeutic option in HIV infection.
    Lancet; 1990 May; 335(8698):1128-30. PubMed ID: 1971867
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein GP120 of human immunodeficiency virus.
    Dis Markers; 1990; 8(4):220-1. PubMed ID: 1982426
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular biological bases of resistance to HIV/AIDS (the hypothesis with elements of the theory).
    Skripal IG
    Mikrobiol Z; 1995; 57(4):89-105. PubMed ID: 8548075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 envelope-specific CD4+ T helper cells from simian/human immunodeficiency virus-infected rhesus monkeys recognize epitopes restricted by MHC class II DRB1*0406 and DRB*W201 molecules.
    Lekutis C; Letvin NL
    J Immunol; 1997 Aug; 159(4):2049-57. PubMed ID: 9257873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antigenic structure of the HIV gp120 envelope glycoprotein.
    Wyatt R; Kwong PD; Desjardins E; Sweet RW; Robinson J; Hendrickson WA; Sodroski JG
    Nature; 1998 Jun; 393(6686):705-11. PubMed ID: 9641684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of T cell receptor dependent activation pathways by HIV-1.
    Maitland AL; Gaulton GN
    Pathol Biol (Paris); 1993 May; 41(5):445-8. PubMed ID: 8414675
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of HIV infection: perspectives].
    Monsuez JJ
    Pathol Biol (Paris); 1992 Jun; 40(6):609-20. PubMed ID: 1383913
    [No Abstract]   [Full Text] [Related]  

  • 13. Impairment of T cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein.
    Schwartz O; Alizon M; Heard JM; Danos O
    Virology; 1994 Jan; 198(1):360-5. PubMed ID: 7903129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentation.
    Chien PC; Chen D; Chen PD; Tuen M; Cohen S; Migueles SA; Connors M; Rosenberg E; Malhotra U; Gonzalez C; Hioe CE
    J Infect Dis; 2004 Mar; 189(5):852-61. PubMed ID: 14976603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection.
    Musey LK; Krieger JN; Hughes JP; Schacker TW; Corey L; McElrath MJ
    J Infect Dis; 1999 Aug; 180(2):278-84. PubMed ID: 10395840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the immunological synapse: a key to HIV-1 pathogenesis?
    Fackler OT; Alcover A; Schwartz O
    Nat Rev Immunol; 2007 Apr; 7(4):310-7. PubMed ID: 17380160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation.
    Wang JM; Ueda H; Howard OM; Grimm MC; Chertov O; Gong X; Gong W; Resau JH; Broder CC; Evans G; Arthur LO; Ruscetti FW; Oppenheim JJ
    J Immunol; 1998 Oct; 161(8):4309-17. PubMed ID: 9780207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor.
    Callahan KM; Fort MM; Obah EA; Reinherz EL; Siliciano RF
    J Immunol; 1990 May; 144(9):3341-6. PubMed ID: 1970352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells.
    Stricker RB; McHugh TM; Moody DJ; Morrow WJ; Stites DP; Shuman MA; Levy JA
    Nature; 1987 Jun 25-Jul 1; 327(6124):710-3. PubMed ID: 2955226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
    Emini EA; Koff WC
    Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.